Development and validation of prediction rules to target care intensification in veteran patients with diabetes
| Autor: | Glen H. Murata, Heather M. Campbell, Allison Murata, Gerald A Charlton |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty endocrine system diseases Population 030209 endocrinology & metabolism Health Informatics Health informatics 03 medical and health sciences primary healthcare 0302 clinical medicine Health Information Management Risk Factors Diabetes mellitus medicine medical informatics Electronic Health Records Humans 030212 general & internal medicine Registries Minority status Risk factor education Glycated haemoglobin Veterans Affairs Original Research Retrospective Studies Veterans Aged 80 and over Glycated Hemoglobin education.field_of_study Primary Health Care business.industry patient care Retrospective cohort study information management Middle Aged medicine.disease Decision Support Systems Clinical Quality Improvement United States Computer Science Applications United States Department of Veterans Affairs Diabetes Mellitus Type 2 Emergency medicine Female business |
| Zdroj: | BMJ Health & Care Informatics |
| ISSN: | 2632-1009 |
| Popis: | BackgroundDiabetes affects 30.3 million people in the USA. Among these people, a major risk factor for microvascular complications is having a glycated haemoglobin (HbA1c) value of ≥75 mmol/mol; therefore, it would be helpful to identify patients who will obtain future HbA1c values of ObjectivesTo develop and validate two prediction rules among patients with diabetes having a baseline HbA1c value of ≥75 mmol/mol: (1) HbA1c measurement ever MethodsRetrospective cohort study using a registry extracting data from the Department of Veterans Affairs’s (VA’s) electronic health records system. Baseline was 1 Jul 2013–30 June 2014; patients were followed up until 31 July 2016.ResultsOur population consisted of 145 659 patients. Across models, predictors were age, sex, minority status, baseline HbA1c value, time, HbA1c≥75 mmol/mol, receiving insulin treatment and consecutive number of HbA1c values of 75 mmol/mol. The overall likelihood of a patient ever having an HbA1cConclusionsWithin each rule, there were similar observed and predicted tertile probabilities; maintaining HbA1c values of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|